NL7901601A - Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen. - Google Patents

Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen.

Info

Publication number
NL7901601A
NL7901601A NL7901601A NL7901601A NL7901601A NL 7901601 A NL7901601 A NL 7901601A NL 7901601 A NL7901601 A NL 7901601A NL 7901601 A NL7901601 A NL 7901601A NL 7901601 A NL7901601 A NL 7901601A
Authority
NL
Netherlands
Prior art keywords
consciousness
perception
medicinal product
motion disorders
disorders
Prior art date
Application number
NL7901601A
Other languages
English (en)
Dutch (nl)
Original Assignee
Nippon Shoji Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shoji Kaisha Ltd filed Critical Nippon Shoji Kaisha Ltd
Publication of NL7901601A publication Critical patent/NL7901601A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7901601A 1978-02-28 1979-02-28 Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen. NL7901601A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2238578A JPS54117034A (en) 1978-02-28 1978-02-28 Treating agent for consciousness and perception motion disorder

Publications (1)

Publication Number Publication Date
NL7901601A true NL7901601A (nl) 1979-08-30

Family

ID=12081179

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7901601A NL7901601A (nl) 1978-02-28 1979-02-28 Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen.

Country Status (4)

Country Link
US (1) US4263286A (xx)
JP (1) JPS54117034A (xx)
DE (1) DE2907778A1 (xx)
NL (1) NL7901601A (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder
IT1123142B (it) * 1979-09-14 1986-04-30 Lpb Ist Farm Uso di glicerilfosforil derivati nella terapia di dislipemie ed epatiti,e composizioni farmaceutiche relative
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
DE3228629A1 (de) * 1982-07-31 1984-02-02 Reifenrath, Rainer Richard Otto, Dr., 3104 Unterlüß Pharmazeutisches erzeugnis zur behandlung der atemwege und verfahren zu seiner herstellung
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
DE3346525C2 (de) * 1983-12-22 1987-03-19 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Zubereitung mit speziellen 1,2-Diacyl-glycero-3-phosphocholinen zur Behandlung von Erkrankungen im Magen-Darmbereich
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US5011964A (en) * 1985-03-07 1991-04-30 Cornell Research Foundation, Inc. Novel diacylglycerophosphoric acid esters and use thereof as substrates in enzyme assays
IT1199972B (it) * 1985-05-08 1989-01-05 Lpb Ist Farm Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
US4923854A (en) * 1986-01-22 1990-05-08 The Liposome Company, Inc. Solubilization of hydrophobic materials using lysophospholipid
IT1212137B (it) * 1987-04-08 1989-11-08 Rosanna Lodi Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
US5001117A (en) * 1989-03-07 1991-03-19 Pharmacaps, Inc. Use of lecithin to restore olfaction and taste
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
IT1255476B (it) * 1992-07-30 1995-11-02 Glicerofosfoderivati farmacologicamente attivi
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
IL118180A (en) * 1996-05-08 2000-12-06 Modus Biolog Membranes Ltd Pharmaceutical compositions comprising a phosphatidic acid (PA) enriched natural phospholipid preparation and the production of such preparation
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
IL121322A (en) * 1997-07-16 2002-07-25 Modus Biolog Membranes Ltd Modular pharmacological preparation of the immune system based on fats and its preparation
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
AU1029500A (en) * 1998-08-29 2000-03-21 Miklos Ghyczy Pharmaceutical and/or diet product
AU777254B2 (en) * 1999-04-20 2004-10-07 Board Of Trustees Of Southern Illinois University, The Methods of treating clinical diseases with isoflavones
AU6595900A (en) * 1999-08-18 2001-03-13 Kyowa Hakko Kogyo Co. Ltd. Hair growth stimulants
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6683066B2 (en) 2001-09-24 2004-01-27 Yanming Wang Composition and treatment method for brain and spinal cord injuries
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7691417B2 (en) 2004-09-02 2010-04-06 Clemson University Research Foundation Tumor and mutation suppressing plant extract

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3772360A (en) * 1969-07-01 1973-11-13 Smithkline Corp Adamantyl substituted glycerophosphoryl(and phosphonyl)ethanolamines

Also Published As

Publication number Publication date
JPS623127B2 (xx) 1987-01-23
US4263286A (en) 1981-04-21
DE2907778C2 (xx) 1990-09-06
JPS54117034A (en) 1979-09-11
DE2907778A1 (de) 1979-08-30

Similar Documents

Publication Publication Date Title
NL7901601A (nl) Geneesmiddel voor bewustzijnsstoornissen en perceptie en bewegingsstoornissen.
NL7701849A (nl) Werkwijze voor de bereiding van geneesmiddelen onder toepassing van pyrethrinoiden.
JPS54101443A (en) Deodorant product for skin care
NL193339B (nl) Gefluorideerd voortbrengsel voor het verzorgen van het gebit.
IT7920291A0 (it) Dispositivo per la preparazione diprodotti di materia termoplastica.
NL188681C (nl) Geneesmiddel voor het verbeteren van de doorbloeding en wondgenezing.
NL7904541A (nl) Wegwerpprodukt met voor vloeistof-doordringbare boven- laag.
JPS55147223A (en) Pharmaceutical medicine
NL7810865A (nl) 6,7-dialkoxy-4-piperidinochinazolinen, farmaceutische preparaten die ze bevatten, en werkwijzen voor de be- reiding daarvan.
NL171327B (nl) Magnetische lendegordel voor medische doeleinden.
IT8222578A0 (it) Prodotto per la cura dei capelli.
GB2013084B (en) Ophthalmic drug dosage
NL7802069A (nl) Pyrrolidinederivaten, werkwijze voor de berei- ding daarvan en dergelijke pyrrolidinederivaten bevattende geneesmiddelen.
IT1126406B (it) 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
NL7903725A (nl) Farmaceutische doseercomponent voor geregelde afgifte.
NL7703237A (nl) Werkwijze voor de bereiding van een veterinair geneesmiddel.
NL187397B (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL187577C (nl) 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
LU81467A1 (fr) Medicaments du groupe des spirocetalines
NL7708917A (nl) Afgeefhouder voor visceuze massa's.
FI810934L (fi) Farmaceutiska produkter
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7714235A (nl) Werkwijze voor de bereiding van nieuwe benzothio- feenderivaten en toepassing van deze derivaten als geneesmiddel.
NL188524C (nl) Werkwijze voor de bereiding van p-aminofenol.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed